Suppr超能文献

流体切应力可改善早期内皮祖细胞的内皮修复潜能,减轻前期高血压相关下降。

Fluid Shear Stress Ameliorates Prehypertension-Associated Decline in Endothelium-Reparative Potential of Early Endothelial Progenitor Cells.

机构信息

Department of Cardiology, First Affiliated Hospital of Jinan University, NO.603, Huangpu Big Road, Tianhe District, Guangzhou City, 510630, China.

Department of Cardiology, Guangdong Province Key Laboratory of Arrhythmia and Electrophysiology, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Guangzhou, 510120, China.

出版信息

J Cardiovasc Transl Res. 2022 Oct;15(5):1049-1063. doi: 10.1007/s12265-022-10235-y. Epub 2022 Apr 7.

Abstract

This study investigated the effects of prehypertension and shear stress on the reendothelialization potential of human early EPCs and explored its potential mechanisms. Early EPCs from the prehypertensive patients showed reduced migration and adhesion in vitro and demonstrated a significantly impaired in vivo reendothelialization capacity. Shear stress pretreatment markedly promoted the in vivo reendothelialization capacity of EPCs. Although basal CXCR4 expression in early EPCs from prehypertensive donors was similar to that from healthy control, SDF-1-induced phosphorylation of CXCR4 was lower in prehypertensive EPCs. Shear stress up-regulated CXCR4 expression and increased CXCR4 phosphorylation, and restored the SDF-1/CXCR4-dependent JAK-2 phosphorylation in prehypertensive EPCs. CXCR4 knockdown or JAK-2 inhibitor treatment prevents against shear stress-induced increase in the migration, adhesion and reendothelialization capacity of the prehypertensive EPCs. Collectively, CXCR4 receptor profoundly modulates the reendothelialization potential of early EPCs. The abnormal CXCR4-mediated JAK-2 signaling may contribute to impaired functions of EPCs from patients with prehypertension.

摘要

本研究旨在探讨高血压前期和切应力对人早期内皮祖细胞(EPC)再内皮化潜能的影响,并探讨其潜在机制。与健康对照组相比,高血压前期患者的早期 EPC 表现出体外迁移和黏附能力降低,体内再内皮化能力显著受损。切应力预处理明显促进了 EPC 的体内再内皮化能力。虽然高血压前期供体的早期 EPC 中 CXCR4 的基础表达与健康对照组相似,但高血压前期 EPC 中 SDF-1 诱导的 CXCR4 磷酸化水平较低。切应力上调 CXCR4 表达并增加 CXCR4 磷酸化水平,并恢复了高血压前期 EPC 中 SDF-1/CXCR4 依赖性 JAK-2 磷酸化。CXCR4 敲低或 JAK-2 抑制剂治疗可预防切应力诱导的高血压前期 EPC 迁移、黏附和再内皮化能力的增加。综上所述,CXCR4 受体可显著调节早期 EPC 的再内皮化潜能。异常的 CXCR4 介导的 JAK-2 信号通路可能导致高血压前期患者 EPC 功能受损。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验